Internal Medicine, Hematology & Oncology · Indianapolis, IN
NPI
1689053761
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1120 W Michigan St, Room 626
Indianapolis, IN, 46202
Phone (317) 278-2686
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
408 services
Medicare patients, 2024
150
Average age 69
Drug cost, 2024
$846K
444 prescriptions
Company payments, 2025
$149
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samantha A Armstrong was code 99214 (office e&m - established), 186 times for 88 patients. In total Samantha A Armstrong billed 408 services in 9 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 186 | 88 | $70.77 | $13K |
| 99213 Office E&M - Established | Facility | 98 | 66 | $46.23 | $4,531 |
| 99205 Office E&M - New | Facility | 28 | 28 | $130.37 | $3,650 |
| 99215 Office E&M - Established | Facility | 25 | 19 | $101.88 | $2,547 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 11 | $55.79 | $1,283 |
By year: 2022 $21K for 292 services; 2023 $29K for 385 services; 2024 $28K for 408 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samantha A Armstrong prescribed most often to Medicare patients was Imatinib Mesylate, with 48 prescriptions and refills. In total Samantha A Armstrong wrote 444 Medicare prescriptions that cost $846K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 48 | 48 | Under 11 | $12K |
| Sorafenib Sorafenib Tosylate | 37 | 37 | Under 11 | $138K |
| Sunitinib Malate Generic | 29 | 29 | Under 11 | $59K |
| Prochlorperazine Maleate Generic | 29 | 29 | Under 11 | $576 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | Under 11 | $1,158 |
| Nortriptyline Hcl Generic | 18 | 28 | Under 11 | $228 |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $171 |
| Potassium Chloride Generic | 14 | 14 | Under 11 | $50.06 |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $198 |
| Pazopanib Hcl Generic | 13 | 13 | Under 11 | $59K |
| Ropinirole Hcl Generic | 12 | 17 | Under 11 | $151 |
| Stivarga Regorafenib | 11 | 11 | Under 11 | $250K |
| Ondansetron Hcl Generic | 11 | 11 | Under 11 | $109 |
| Olanzapine Generic | 11 | 25 | Under 11 | $393 |
Brand drugs: 50 claims; generic drugs: 394 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samantha A Armstrong $149 ($149 in general payments such as food, travel and fees) from 2 companies. The largest payer was Aadi Bioscience, Inc. with $127.
| Company | Payments | Amount |
|---|---|---|
| Aadi Bioscience, Inc. | 1 | $127 |
| Abbvie Inc. ABBV | 1 | $21.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.